EMILY QUINN: Open Payments
NPI 1881242840 · MONTVALE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$460 in 8 payments from 6 companies in 2025. Trend: 2023 $517 · 2024 $275 · 2025 $460
Food & beverage: $460
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 1 | $123 |
| Gilead Sciences, Inc. | 1 | $122 |
| E.R. Squibb & Sons, L.L.C. | 1 | $120 |
| Novartis Pharmaceuticals Corporation | 3 | $60 |
| Blueprint Medicines Corporation | 1 | $19 |
| SANOFI-AVENTIS U.S. LLC | 1 | $17 |
Products named: RYBREVANT, REBLOZYL, Fabhalta, AYVAKIT, REZUROCK.
Industry payments across NJ — which companies pay providers there.
